Prognostic Value of PET-Based Metabolic Markers in Nivolumab-Treated NSCLC


MÜTEVELİZADE G., AYDIN N., ERDOĞAN A. P., BOZDEMİR B. Ç., KOLKIRAN N., BİLGİN B. E.

Molecular Oncologic Imaging, cilt.5, sa.5, ss.26-37, 2025 (Hakemli Dergi)